- +131.4% price growth over the last year
- High gross margin of 92.6%
- Low bankruptcy risk (Altman Z-Score: 8.90)
Red day on Thursday for Axsome Therapeutics
(Updated on Jun 25, 2026)
The Axsome Therapeutics stock price fell by -0.248% on the last day (Thursday, 25th Jun 2026) from $237.92 to $237.33. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 3.41% from a day low at $236.60 to a day high of $244.67. The price has fallen in 7 of the last 10 days and is down by -3.66% for this period. Volume has increased on the last day by 467 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $309.81 million.
Given the current short-term trend, the stock is expected to rise 55.21% during the next 3 months and, with a 90% probability hold a price between $368.35 and $415.09 at the end of this 3-month period.
AXSM Signals & Forecast
The Axsome Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $245.66. On a fall, the stock will find some support from the long-term average at approximately $235.57. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 12, 2026, and so far it has fallen -6.99%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Axsome Therapeutics stock
On the downside, the stock finds support just below today's level from accumulated volume at $223.70 and $207.75. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Axsome Therapeutics finds support just below today's level at $223.70. If this is broken, then the next support from accumulated volume will be at $207.75 and $206.53.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $8.07 between high and low, or 3.41%. For the last week, the stock has had daily average volatility of 4.01%.
Our recommended stop-loss: $226.56 (-4.54%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 8 days ago.)
Trading Expectations (AXSM) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Axsome Therapeutics to open at $239.53, and during the day (based on 14 day Average True Range), to move between $233.05 and $241.61, which gives a possible trading interval of +/-$8.56 (+/-3.67%) up or down from last closing price. If Axsome Therapeutics takes out the full calculated possible swing range there will be an estimated 3.67% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $237.92 (0.25%) than the support at $223.70 (5.74%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Axsome Therapeutics stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Axsome Therapeutics stock to perform well in the short-term.
Current score:
3.173
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 26, 2026 - $239.53 ( 0.93%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
AXSM Performance
Trading levels for AXSM
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 247.61 | 4.33% |
| R2 | 244.52 | 3.03% |
| R1 | 242.62 | 2.23% |
| Price | 237.33 | |
| S1 | 236.45 | -0.372% |
| S2 | 234.54 | -1.18% |
| S3 | 231.46 | -2.47% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 245.64 | 3.50% |
| R2 | 241.97 | 1.96% |
| R1 | 237.92 | 0.249% |
| Price | 237.33 | |
| S1 | 223.70 | -5.74% |
| S2 | 207.75 | -12.46% |
| S3 | 206.53 | -12.98% |
FAQ
Click here for our free guide on how to buy Axsome Therapeutics Stock.
Buy AXSM